Yvon Bastard
Vorstandsvorsitzender bei HTL SAS
Aktive Positionen von Yvon Bastard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HTL SAS
HTL SAS BiotechnologyHealth Technology HTL SAS manufactures and develops biological polymers for the pharmaceutical and medical fields. The firm’s products include Hyaluronan, Chrondroitin and Heparosan. The company was founded in 1992 and is headquartered in Javene, France. | Vorstandsvorsitzender | - | - |
Horace Holding SAS
Horace Holding SAS Investment ManagersFinance Horace Holding SAS provides fund management services. The company is based in Javene, France and has subsidiaries in France. The French company was founded in 2018. Yvon Bastard has been the CEO of the company since 2018. | Vorstandsvorsitzender | 14.12.2018 | - |
Präsident | 14.12.2018 | - |
Karriereverlauf von Yvon Bastard
Ehemalige bekannte Positionen von Yvon Bastard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Axyntis SAS
Axyntis SAS Chemicals: SpecialtyProcess Industries Axyntis SAS produces fine chemicals. It produces intermediates and active ingredients for the pharmaceutical, animal health, and agrochemical sectors. The company was founded in 2007 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | 01.01.2008 | - |
Statistik
International
Frankreich | 4 |
Operativ
Chief Executive Officer | 2 |
Director/Board Member | 1 |
President | 1 |
Sektoral
Process Industries | 2 |
Health Technology | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Axyntis SAS
Axyntis SAS Chemicals: SpecialtyProcess Industries Axyntis SAS produces fine chemicals. It produces intermediates and active ingredients for the pharmaceutical, animal health, and agrochemical sectors. The company was founded in 2007 and is headquartered in Paris, France. | Process Industries |
HTL SAS
HTL SAS BiotechnologyHealth Technology HTL SAS manufactures and develops biological polymers for the pharmaceutical and medical fields. The firm’s products include Hyaluronan, Chrondroitin and Heparosan. The company was founded in 1992 and is headquartered in Javene, France. | Health Technology |
Horace Holding SAS
Horace Holding SAS Investment ManagersFinance Horace Holding SAS provides fund management services. The company is based in Javene, France and has subsidiaries in France. The French company was founded in 2018. Yvon Bastard has been the CEO of the company since 2018. | Finance |
- Börse
- Insiders
- Yvon Bastard
- Erfahrung